Thomas Stegmann is 10% at CardioVascular BioTherapeutics, Inc. (CVBT). They have made 17 open-market trades across 2 companies since 2006, most recently 2009-08-11.
CIK 0001314771
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $199K since 2006, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CVBT | SELL | 2009-08-10 | 2009-08-18 | $0.26 | $399K | N/A | N/A | N/A |
| CVBT | SELL | 2009-08-04 | 2009-08-10 | $0.18 | $631K | N/A | N/A | N/A |
| CVBT | SELL | 2009-07-28 | 2009-08-04 | $0.16 | $180K | N/A | N/A | N/A |
| CVBT | SELL | 2009-07-21 | 2009-07-28 | $0.15 | $249K | N/A | N/A | N/A |
| CVBT | SELL | 2009-07-14 | 2009-07-21 | $0.16 | $62K | N/A | N/A | N/A |
| CVBT | SELL | 2009-07-07 | 2009-07-14 | $0.18 | $62K | N/A | N/A | N/A |
| CVBT | SELL | 2009-06-29 | 2009-07-07 | $0.18 | $84K | N/A | N/A | N/A |
| CVBT | SELL | 2009-06-22 | 2009-06-30 | $0.19 | $111K | N/A | N/A | N/A |
| CVBT | SELL | 2009-06-15 | 2009-06-23 | $0.20 | $98K | N/A | N/A | N/A |
| CVBT.PK | SELL | 2009-05-29 | 2009-06-17 | $0.24 | $347K | N/A | N/A | N/A |
| CVBT.PK | SELL | 2009-04-28 | 2009-05-14 | $0.14 | $72K | N/A | N/A | N/A |
| CVBT.PK | SELL | 2009-03-25 | 2009-04-29 | $0.19 | $190K | N/A | N/A | N/A |
| CVBT | BUY | 2006-12-12 | 2006-12-12 | $1.10 | $33K | N/A | N/A | N/A |
| CVBT | BUY | 2006-03-31 | 2006-04-04 | $7.74 | $54K | N/A | N/A | N/A |
| CVBT | BUY | 2006-03-30 | 2006-03-31 | $7.70 | $17K | N/A | N/A | N/A |
| CVBT | BUY | 2006-03-27 | 2006-03-31 | $7.34 | $57K | N/A | N/A | N/A |
| CVBT | BUY | 2006-03-22 | 2006-03-24 | $6.89 | $38K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.